论文信息 - CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma - 字舞流文

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma

T. Kodama | M. Shigekawa | Ryoko Yamada | H. Hikita | R. Sakamori | T. Tatsumi | T. Takehara | Yuta Myojin | Shigeki Suemura | Minoru Shigekawa | Hayato Hikita